CCDC24
gene geneOn this page
Also known as MGC45441
Summary
CCDC24 (coiled-coil domain containing 24, HGNC:28688) is a protein-coding gene on chromosome 1p34.1, encoding Coiled-coil domain-containing protein 24 (Q8N4L8).
Predicted to act upstream of or within blastocyst hatching.
Source: NCBI Gene 149473 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 48 total
- MANE Select transcript:
NM_152499
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28688 |
| Approved symbol | CCDC24 |
| Name | coiled-coil domain containing 24 |
| Location | 1p34.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC45441 |
| Ensembl gene | ENSG00000159214 |
| Ensembl biotype | protein_coding |
| Entrez | 149473 |
Gene structure
Transcript identifiers
Ensembl transcripts: 43 — 34 protein_coding, 5 nonsense_mediated_decay, 2 protein_coding_CDS_not_defined, 2 retained_intron
ENST00000372318, ENST00000460543, ENST00000463846, ENST00000466180, ENST00000472562, ENST00000479055, ENST00000485811, ENST00000486064, ENST00000486504, ENST00000490064, ENST00000490563, ENST00000857675, ENST00000857676, ENST00000857677, ENST00000857678, ENST00000857679, ENST00000857680, ENST00000857681, ENST00000857682, ENST00000857683, ENST00000857684, ENST00000857685, ENST00000857686, ENST00000857687, ENST00000857688, ENST00000857689, ENST00000857690, ENST00000912584, ENST00000912585, ENST00000912586, ENST00000912587, ENST00000912588, ENST00000912589, ENST00000912590, ENST00000912591, ENST00000968710, ENST00000968711, ENST00000968712, ENST00000968713, ENST00000968714, ENST00000968715, ENST00000968716, ENST00000968717
RefSeq mRNA: 4 — MANE Select: NM_152499
NM_001349127, NM_001349128, NM_001349129, NM_152499
CCDS: CCDS507
Canonical transcript exons
ENST00000372318 — 9 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001187563 | 43992212 | 43992387 |
| ENSE00001237118 | 43991599 | 43991746 |
| ENSE00003468545 | 43993887 | 43993964 |
| ENSE00003524624 | 43992523 | 43992639 |
| ENSE00003558834 | 43995938 | 43996528 |
| ENSE00003703037 | 43995601 | 43995670 |
| ENSE00003703108 | 43995778 | 43995856 |
| ENSE00003703876 | 43995108 | 43995162 |
| ENSE00003709148 | 43991847 | 43992004 |
Expression profiles
Bgee: expression breadth ubiquitous, 164 present calls, max score 97.34.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 3.5312 / max 41.7298, expressed in 1300 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 2583 | 2.5900 | 1204 |
| 2585 | 0.6881 | 336 |
| 2582 | 0.2206 | 72 |
| 2584 | 0.0325 | 8 |
Top tissues by expression
252 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right uterine tube | UBERON:0001302 | 97.34 | gold quality |
| adenohypophysis | UBERON:0002196 | 93.28 | gold quality |
| pituitary gland | UBERON:0000007 | 91.83 | gold quality |
| left testis | UBERON:0004533 | 91.71 | gold quality |
| right testis | UBERON:0004534 | 91.61 | gold quality |
| pancreatic ductal cell | CL:0002079 | 90.67 | silver quality |
| right lobe of thyroid gland | UBERON:0001119 | 90.28 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 90.14 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 89.60 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 88.71 | gold quality |
| thyroid gland | UBERON:0002046 | 88.64 | gold quality |
| testis | UBERON:0000473 | 88.56 | gold quality |
| metanephros cortex | UBERON:0010533 | 88.18 | gold quality |
| right frontal lobe | UBERON:0002810 | 87.90 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 87.55 | gold quality |
| bronchial epithelial cell | CL:0002328 | 87.16 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 87.15 | gold quality |
| bronchus | UBERON:0002185 | 86.28 | gold quality |
| amygdala | UBERON:0001876 | 86.18 | gold quality |
| hypothalamus | UBERON:0001898 | 85.98 | gold quality |
| nucleus accumbens | UBERON:0001882 | 84.60 | gold quality |
| endocervix | UBERON:0000458 | 84.45 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 84.33 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 84.28 | gold quality |
| right adrenal gland | UBERON:0001233 | 83.93 | gold quality |
| body of pancreas | UBERON:0001150 | 83.53 | gold quality |
| caudate nucleus | UBERON:0001873 | 82.84 | gold quality |
| minor salivary gland | UBERON:0001830 | 82.80 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 82.60 | gold quality |
| prefrontal cortex | UBERON:0000451 | 82.55 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 6.29 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
18 targeting CCDC24, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4482-3P | 99.98 | 72.50 | 3147 |
| HSA-MIR-7152-5P | 99.60 | 69.33 | 2094 |
| HSA-MIR-3128 | 99.50 | 67.85 | 1258 |
| HSA-MIR-6507-3P | 99.35 | 67.32 | 1059 |
| HSA-MIR-593-3P | 99.22 | 67.28 | 1327 |
| HSA-MIR-4755-3P | 98.77 | 65.59 | 1915 |
| HSA-MIR-6731-3P | 98.61 | 67.86 | 749 |
| HSA-MIR-4421 | 97.99 | 64.89 | 701 |
| HSA-MIR-5699-3P | 97.81 | 65.00 | 861 |
| HSA-MIR-3921 | 97.81 | 67.45 | 1431 |
| HSA-MIR-3652 | 97.71 | 65.43 | 1890 |
| HSA-MIR-4430 | 97.47 | 65.61 | 1813 |
| HSA-MIR-4640-5P | 97.42 | 66.33 | 1543 |
| HSA-MIR-4726-5P | 97.24 | 65.67 | 1299 |
| HSA-MIR-4653-5P | 97.22 | 67.72 | 1429 |
| HSA-MIR-6736-3P | 96.98 | 65.22 | 1342 |
| HSA-MIR-7847-3P | 96.63 | 64.58 | 952 |
| HSA-MIR-6820-5P | 94.04 | 61.13 | 161 |
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | ccdc24 | ENSDARG00000038793 |
| mus_musculus | Ccdc24 | ENSMUSG00000078588 |
| rattus_norvegicus | Ccdc24 | ENSRNOG00000019586 |
Protein
Protein identifiers
Coiled-coil domain-containing protein 24 — Q8N4L8 (reviewed: Q8N4L8)
All UniProt accessions (5): Q8N4L8, V9GY72, V9GYB9, V9GYE2, V9GYM6
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8N4L8-1 | 1 | yes |
| Q8N4L8-2 | 2 |
RefSeq proteins (4): NP_001336056, NP_001336057, NP_001336058, NP_689712* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR031367 | CCDC24 | Family |
Pfam: PF15669
UniProt features (7 total): region of interest 2, chain 1, coiled-coil region 1, compositionally biased region 1, splice variant 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8N4L8-F1 | 67.31 | 0.16 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 41 (showing top):
MAZ_Q6, SREBP1_02, PAX8_B, chr1p34, E4F1_Q6, DELASERNA_MYOD_TARGETS_DN, AP2GAMMA_01, AAGCACA_MIR218, MZF1_02, AP2ALPHA_01, HOXB4_TARGET_GENES, ZNF407_TARGET_GENES, ZNF667_TARGET_GENES, PAX8_01, MIR6507_3P
GO Biological Process (1): blastocyst hatching (GO:0001835)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| blastocyst development | 1 |
| hatching | 1 |
| binding | 1 |
Protein interactions and networks
STRING
406 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CCDC24 | ERI3 | O43414 | 526 |
| CCDC24 | C5orf52 | A6NGY3 | 515 |
| CCDC24 | ISCA1 | Q9BUE6 | 503 |
| CCDC24 | ZNF644 | Q9H582 | 500 |
| CCDC24 | WDR89 | Q96FK6 | 499 |
| CCDC24 | RNF220 | Q5VTB9 | 497 |
| CCDC24 | CFAP97D1 | B2RV13 | 478 |
| CCDC24 | TIGD5 | Q53EQ6 | 478 |
| CCDC24 | B4GALT2 | O60909 | 471 |
| CCDC24 | KLF18 | A0A0U1RQI7 | 451 |
| CCDC24 | ANKRD7 | Q92527 | 431 |
| CCDC24 | SMIM14 | Q96QK8 | 427 |
| CCDC24 | LRRIQ3 | A6PVS8 | 414 |
| CCDC24 | ZFP14 | Q9HCL3 | 409 |
| CCDC24 | IFT22 | Q9H7X7 | 407 |
IntAct
124 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| USHBP1 | CCDC24 | psi-mi:“MI:0915”(physical association) | 0.720 |
| CCDC24 | USHBP1 | psi-mi:“MI:0915”(physical association) | 0.720 |
| CCDC24 | GATA1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CCDC24 | RNF31 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CDC23 | CCDC24 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GATA1 | CCDC24 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RNF31 | CCDC24 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CCDC24 | CDC23 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CCDC24 | KRTAP6-1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CCDC24 | KRTAP19-7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TTC23L | CCDC24 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP6-3 | CCDC24 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRT34 | CCDC24 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MAGEA6 | CCDC24 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TRIP6 | CCDC24 | psi-mi:“MI:0915”(physical association) | 0.560 |
| USP54 | CCDC24 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CCDC24 | AKAP8L | psi-mi:“MI:0915”(physical association) | 0.560 |
| OIP5 | CCDC24 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TRIM42 | CCDC24 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CCDC24 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| KRT33B | CCDC24 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP19-6 | CCDC24 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (40): CCDC24 (Two-hybrid), CCDC24 (Two-hybrid), CCDC24 (Two-hybrid), CCDC24 (Two-hybrid), REN (Two-hybrid), CCDC24 (Affinity Capture-MS), CCDC24 (Two-hybrid), CCDC24 (Two-hybrid), CCDC24 (Two-hybrid), CCDC24 (Two-hybrid), CCDC24 (Two-hybrid), CCDC24 (Two-hybrid), CCDC24 (Two-hybrid), CCDC24 (Two-hybrid), CCDC24 (Two-hybrid)
ESM2 similar proteins: A0A1B0GVZ6, A0A1W2PR82, A0A286YDK6, A2A9F4, A2VE02, A5D7I0, A6H7B4, A6NE82, A6NEV1, A6NJB7, A6NJI1, A6NJJ6, A6QP24, A6QPM6, A8MZG2, D3ZAQ5, D4AAA5, O94850, O95873, P0C7X2, P50617, P70339, Q0P5M0, Q2KIL8, Q2KIS6, Q3UN58, Q3ZCQ2, Q5JPB2, Q5M844, Q5VZ46, Q6AY88, Q6GQX2, Q6NZ36, Q6ZW13, Q76NI1, Q7TNS8, Q80TS7, Q86YN6, Q8C1M2, Q8K2F3
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 36 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Keratinization | 9 | 22.8× | 8e-09 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
48 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 37 |
| Likely benign | 5 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1449 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:43991691:G:GT | donor_gain | 0.9900 |
| 1:43991706:A:T | donor_gain | 0.9900 |
| 1:43991727:G:T | donor_gain | 0.9900 |
| 1:43991945:G:GT | donor_gain | 0.9900 |
| 1:43991956:G:GT | donor_gain | 0.9900 |
| 1:43992016:G:T | donor_gain | 0.9900 |
| 1:43995083:T:TA | acceptor_gain | 0.9900 |
| 1:43995599:A:AG | acceptor_gain | 0.9900 |
| 1:43995600:G:GG | acceptor_gain | 0.9900 |
| 1:43995600:GC:G | acceptor_gain | 0.9900 |
| 1:43995600:GCGCT:G | acceptor_gain | 0.9900 |
| 1:43995776:A:AG | acceptor_gain | 0.9900 |
| 1:43995777:G:GG | acceptor_gain | 0.9900 |
| 1:43995777:GA:G | acceptor_gain | 0.9900 |
| 1:43995852:CACAG:C | donor_loss | 0.9900 |
| 1:43995853:ACAG:A | donor_loss | 0.9900 |
| 1:43995854:CAGG:C | donor_loss | 0.9900 |
| 1:43995855:AGG:A | donor_loss | 0.9900 |
| 1:43995856:GGTA:G | donor_loss | 0.9900 |
| 1:43995857:G:T | donor_loss | 0.9900 |
| 1:43995858:T:A | donor_loss | 0.9900 |
| 1:43991950:G:GT | donor_gain | 0.9800 |
| 1:43991966:G:GT | donor_gain | 0.9800 |
| 1:43991966:G:T | donor_gain | 0.9800 |
| 1:43993793:T:TA | acceptor_gain | 0.9800 |
| 1:43993795:T:TA | acceptor_gain | 0.9800 |
| 1:43995076:C:A | acceptor_gain | 0.9800 |
| 1:43995077:G:A | acceptor_gain | 0.9800 |
| 1:43995668:CAGGT:C | donor_loss | 0.9800 |
| 1:43995669:AG:A | donor_loss | 0.9800 |
AlphaMissense
1962 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:43992339:T:C | L85P | 0.978 |
| 1:43992569:T:C | F117L | 0.976 |
| 1:43992571:T:A | F117L | 0.976 |
| 1:43992571:T:G | F117L | 0.976 |
| 1:43991905:G:C | W9C | 0.973 |
| 1:43991905:G:T | W9C | 0.973 |
| 1:43992573:C:A | A118D | 0.973 |
| 1:43991903:T:A | W9R | 0.971 |
| 1:43991903:T:C | W9R | 0.971 |
| 1:43991984:A:C | S36R | 0.971 |
| 1:43991986:C:A | S36R | 0.971 |
| 1:43991986:C:G | S36R | 0.971 |
| 1:43995781:T:C | L209P | 0.969 |
| 1:43995794:G:C | K213N | 0.958 |
| 1:43995794:G:T | K213N | 0.958 |
| 1:43993961:T:C | L165P | 0.956 |
| 1:43991953:G:C | K25N | 0.949 |
| 1:43991953:G:T | K25N | 0.949 |
| 1:43992371:G:C | A96P | 0.949 |
| 1:43992339:T:A | L85H | 0.945 |
| 1:43992370:A:C | K95N | 0.945 |
| 1:43992370:A:T | K95N | 0.945 |
| 1:43992539:T:A | W107R | 0.945 |
| 1:43992539:T:C | W107R | 0.945 |
| 1:43991994:T:C | L39P | 0.943 |
| 1:43992351:T:C | L89P | 0.941 |
| 1:43992570:T:C | F117S | 0.938 |
| 1:43991963:G:T | G29W | 0.933 |
| 1:43991964:G:T | G29V | 0.930 |
| 1:43992561:T:A | V114D | 0.926 |
dbSNP variants (sampled 300 via entrez): RS1000535126 (1:43995182 C>G), RS1000661808 (1:43989698 C>T), RS1000913421 (1:43992898 A>T), RS1001245835 (1:43992963 T>C), RS1001475089 (1:43994563 C>G,T), RS1001940026 (1:43990585 T>A), RS1002832901 (1:43993293 A>G,T), RS1002992394 (1:43991337 G>A), RS1003350691 (1:43991520 C>A,G,T), RS1003454575 (1:43994819 G>A), RS1005219902 (1:43993728 GGCAGAGCTCATTT>G), RS1005235205 (1:43995103 C>A,T), RS1005484438 (1:43994870 G>A), RS1005822864 (1:43989716 C>T), RS1005830463 (1:43996374 A>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004521_235 | Autism spectrum disorder or schizophrenia | 4.000000e-10 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
20 total (human), top 20 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Tunicamycin | decreases expression, increases expression | 2 |
| Particulate Matter | decreases expression, increases abundance, affects cotreatment, increases expression | 2 |
| triphenyl phosphate | affects expression | 1 |
| tris(2-butoxyethyl) phosphate | affects expression | 1 |
| perfluorooctane sulfonic acid | increases expression | 1 |
| ICG 001 | affects expression | 1 |
| jinfukang | increases expression, affects cotreatment | 1 |
| 4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid | increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Ethanol | affects cotreatment, increases abundance, increases expression | 1 |
| Calcitriol | increases expression, affects cotreatment | 1 |
| Cisplatin | increases expression, affects cotreatment | 1 |
| Gasoline | affects cotreatment, increases abundance, increases expression | 1 |
| Polycyclic Aromatic Hydrocarbons | affects cotreatment, increases abundance, increases expression | 1 |
| Smoke | decreases expression | 1 |
| Testosterone | affects cotreatment, increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Urethane | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.